Synthesis and reactivity of novel pyrrolo[1,2-a]pyrazine derivatives

被引:5
作者
Voievudskyi, Maxim [1 ]
Astakhina, Valeriia [1 ]
Kryshchyk, Oxana [1 ]
Petuhova, Olena [2 ]
Shyshkina, Svetlana [3 ,4 ]
机构
[1] Ukrainian State Univ Chem Technol, Dnepropetrovsk, Ukraine
[2] Dnipropetrovsk Natl Univ O Honchar, Dnepropetrovsk, Ukraine
[3] Natl Acad Sci Ukraine, SSI Inst Single Crystals, Kharkov, Ukraine
[4] Kharkov Natl Univ, Kharkov, Ukraine
来源
MONATSHEFTE FUR CHEMIE | 2016年 / 147卷 / 04期
关键词
Azomethine; Cyclizations; Crystal structure; Schiff bases; POTENT; AGONISTS; AS-3201;
D O I
10.1007/s00706-015-1619-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This research describes the utility of ethyl 2-amino-6,8-dimethyl-1,3-dioxo-1,2,3,4-tetrahydropyrrolo-[1,2-a]pyrazine-7-carboxylate as a key starting material for synthesis of novel analogues of natural alkaloid peramine. This heterocyclic compound was synthesized by the reaction of corresponding N-alkylpyrrole with hydrazine hydrate in good yield. In further step, chemical reactivity of N-aminopiperazine was studied towards some electrophilic reagents such as carbonyl compounds, triethyl orthoformate, nitrous acid, acetylenedicarboxylic acid. The new compounds were characterized by H-1 and C-13 NMR, IR, elemental analysis, and X-ray crystallographic study.
引用
收藏
页码:783 / 789
页数:7
相关论文
共 12 条
[1]  
Abiati G, 2006, SYNLETT, V73
[2]   Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists [J].
Arban, Roberto ;
Bianchi, Federica ;
Buson, Alberto ;
Cremonesi, Susanna ;
Di Fabio, Romano ;
Gentile, Gabriella ;
Micheli, Fabrizio ;
Pasquarello, Alessandra ;
Pozzan, Alfonso ;
Tarsi, Luca ;
Terreni, Silvia ;
Tonelli, Federica .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) :5044-5049
[3]   Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy [J].
Bril, V ;
Buchanan, RA .
DIABETES CARE, 2006, 29 (01) :68-72
[4]   Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 1: Perhydropyrrole[1,2-a]pyrazines [J].
Dawidowski, Maciej ;
Herold, Franciszek ;
Chodkowski, Andrzej ;
Kleps, Jerzy ;
Szulczyk, Pawel ;
Wilczek, Marcin .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (10) :4859-4869
[5]  
Gudasheva T.A., 1996, PHARM CHEM J, V30, P562
[6]   Novel, highly potent aldose reductase inhibitors:: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-α]pyrazine-4-spiro-3′-pyrrolidine-1,2′,3,5′-tetrone (AS-3201) and its congeners [J].
Negoro, T ;
Murata, P ;
Ueda, S ;
Fujitani, B ;
Ono, Y ;
Kuromiya, A ;
Komiya, M ;
Suzuki, K ;
Matsumoto, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :4118-4129
[7]  
Olson K, 1979, ACTA CHEM SCAND B, V33, P125
[8]   Novel selective and partial agonists of 5-HT3 receptors .1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines [J].
Rault, S ;
Lancelot, JC ;
Prunier, H ;
Robba, M ;
Renard, P ;
Delagrange, P ;
Pfeiffer, B ;
Caignard, DH ;
GuardiolaLemaitre, B ;
Hamon, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :2068-2080
[9]   Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold [J].
Richter, H. G. F. ;
Freichel, C. ;
Huwyler, J. ;
Nakagawa, T. ;
Nettekoven, M. ;
Plancher, J. -M. ;
Raab, S. ;
Roche, O. ;
Schuler, F. ;
Taylor, S. ;
Ullmer, C. ;
Wiegand, R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) :5713-5717
[10]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122